Arcus Biosciences (RCUS) Retained Earnings (2017 - 2026)

Arcus Biosciences' Retained Earnings history runs 10 years deep, the most recent figure standing at -$1.0 million for Q1 2026.

• In Q1 2026, Retained Earnings rose 99.92% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$1.0 million (up 99.92% YoY), while the FY2024 annual figure was -$1.1 billion, down 33.33% from the prior year.
• Retained Earnings was -$1.0 million for Q1 2026 at Arcus Biosciences, up from -$1.4 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$1.0 million in Q1 2024 to a low of -$1.4 billion in Q3 2025.
• Historically, Retained Earnings has averaged -$619.7 million across 5 years, with a median of -$655.0 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Retained Earnings plunged 17167250.0% in 2022, then jumped 99.92% in 2026.
• A 5-year view of Retained Earnings shows it stood at -$542.0 million in 2022, then tumbled by 56.64% to -$849.0 million in 2023, then sank by 33.33% to -$1.1 billion in 2024, then slipped by 21.82% to -$1.4 billion in 2025, then soared by 99.93% to -$1.0 million in 2026.
• The last three Retained Earnings figures came in at -$1.0 million (Q1 2026), -$1.4 billion (Q3 2025), and -$1.2 billion (Q2 2025), per Business Quant data.